| Category | Source | Advantages | Disadvantages | Ref. |
| Embryonic stem cells | Embryonic tissues or developing nervous system | Pluripotency, nonimmunogenic | Insufficient sources, ethical problems, possible tumorigenesis | [11, 12] | Induced pluripotent stem cells | Somatic cells | Pluripotency, no ethical problems, sufficient sources | Unstable induction, possible infection | [11, 13] | Adult neural stem cells | Adult neural tissue | Multipotency, no ethical problems | Insufficient sources, hard acquisition, purified problems | [11, 14] | SKPs | Dermis | Multipotency, no ethical problems, sufficient sources, easy acquisition | Relatively low neurogenic cells, purified problems | [15, 16] | Mesenchymal stem cells | Including bone marrow, adipose tissue | Multipotency, no ethical problems, sufficient sources | Relatively low neurogenic cells, purified problems, relatively hard acquisition | [11, 17] |
|
|